WaveMark, Inc.

WaveMark, Inc. offers advanced clinical supply chain solutions that enhance healthcare efficiency through integrated data-driven technologies. Their focus is on improving inventory management and patient safety in the healthcare sector. WaveMark, Inc.

specializes in clinical supply chain solutions, providing advanced analytics and technology to healthcare organizations. The company was acquired by Cardinal Health in February 2014, with financial terms undisclosed. Headquartered in Littleton, US, WaveMark aims to improve healthcare delivery efficiency. The company’s founder has a history of establishing successful ventures in the healthcare space.

WaveMark has raised a total of USD 3. 90 mn, with its latest funding round being a VENTURE DEBT round of USD 2. 80 mn. WaveMark™ Solutions, a division of Cardinal Health, provides integrated, data-driven clinical supply chain solutions designed to improve healthcare delivery efficiency.

Key offerings include WaveMark™ Clinical Supply Chain Solutions powered by IntelliWave™ Technology, which delivers real-time visibility and insights for inventory management through advanced analytics, barcode, and RFID technology. Their solutions cater to hospitals, procedural labs, clinical labs, and nursing units across the US, Canada, and select regions in Europe. WaveMark™ Solutions generates revenue primarily through business-to-business transactions with healthcare facilities, including hospitals and clinics. Their revenue model is based on subscription services and partnerships, allowing clients to access tailored clinical supply chain solutions.

These contracts often extend over the long term, enabling healthcare providers to incorporate WaveMark™’s analytics and automation technologies into their operations. Specific pricing details are not disclosed publicly. While specific new products or release dates are not mentioned for WaveMark, the acquisition by Cardinal Health may facilitate new strategic directions in product development. The company aims to expand its market presence, targeting growth in international regions, particularly in Europe.

Following the VENTURE DEBT funding in February 2014, WaveMark is expected to utilize the resources to enhance its clinical supply chain offerings and support its expansion plans.